{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:54:36Z","timestamp":1793120076568,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"BC Cancer Foundation"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ygyno.2019.03.098","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:53:00Z","timestamp":1553561580000},"page":"487-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma"],"prefix":"10.1016","volume":"153","author":[{"given":"Heidi","family":"Britton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-4472","authenticated-orcid":false,"given":"Leo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mruganka","family":"Kale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Burleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Senz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McConechy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6003-485X","authenticated-orcid":false,"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.03.098_bb0005","doi-asserted-by":"crossref","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136:E359\u201386.","DOI":"10.1002\/ijc.29210"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0010","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0015","series-title":"SEER Stat Fact Sheets: Endometrial Cancer","year":"2015"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0020","doi-asserted-by":"crossref","unstructured":"Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, et al. Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J. Korean Med. Sci. 2010;25:1113\u201321.","DOI":"10.3346\/jkms.2010.25.8.1113"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0025","series-title":"2010 Annual Report of Cancer Statistics in Korea. Seoul, Korea","author":"Welfare MoHa. Ministry of Health and Welfare","year":"2012"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0030","series-title":"New Cancer Diagnoses, British Columbia, 2015 by Cancer Type, Age at Diagnosis and Gender","author":"Agency BCC","year":"2015"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0035","doi-asserted-by":"crossref","unstructured":"Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet. Gynecol.. 2013;121:709\u201316.","DOI":"10.1097\/AOG.0b013e3182864350"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0040","doi-asserted-by":"crossref","unstructured":"Evans EC, Matteson KA, Orejuela FJ, Alperin M, Balk EM, El-Nashar S, et al. Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review. Obstet. Gynecol.. 2016;128:476\u201385.","DOI":"10.1097\/AOG.0000000000001592"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0045","doi-asserted-by":"crossref","unstructured":"La Russa M, Zapardiel I, Halaska MJ, Zalewski K, Laky R, Dursun P, et al. Conservative management of endometrial cancer: a survey amongst European clinicians. Arch. Gynecol. Obstet.. 2018;298:373\u201380.","DOI":"10.1007\/s00404-018-4820-7"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2015.02.028","article-title":"Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors","volume":"138","author":"Burleigh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0055","doi-asserted-by":"crossref","unstructured":"Talhouk A, McConechy MK, Leung S, Li-Chang HH, Kwon JS, Melnyk N, et al. A clinically applicable molecular-based classification for endometrial cancers. Br. J. Cancer. 2015;113:299\u2013310.","DOI":"10.1038\/bjc.2015.190"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0060","doi-asserted-by":"crossref","unstructured":"Talhouk A, McConechy MK, Leung S, Yang W, Lum A, Senz J, et al. Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123:802\u201313.","DOI":"10.1002\/cncr.30496"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0065","doi-asserted-by":"crossref","unstructured":"Kommoss S, McConechy MK, Kommoss F, Leung S, Bunz A, Magrill J, et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann. Oncol.. 2018.","DOI":"10.1093\/annonc\/mdy058"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0070","doi-asserted-by":"crossref","unstructured":"Stelloo E, Bosse T, Nout RA, MacKay HJ, Church DN, Nijman HW, et al. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Mod. Pathol.. 2015;28:836\u201344.","DOI":"10.1038\/modpathol.2015.43"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0075","doi-asserted-by":"crossref","unstructured":"Stelloo E, Nout RA, Osse EM, Jurgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin. Cancer Res.. 2016;22:4215\u201324.","DOI":"10.1158\/1078-0432.CCR-15-2878"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0080","doi-asserted-by":"crossref","unstructured":"Talhouk A, Hoang LN, McConechy MK, Nakonechny Q, Leo J, Cheng A, et al. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment. Gynecol. Oncol.. 2016;143:46\u201353.","DOI":"10.1016\/j.ygyno.2016.07.090"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0085","doi-asserted-by":"crossref","unstructured":"Stelloo E, Nout RA, Naves LC, Ter Haar NT, Creutzberg CL, Smit VT, et al. High concordance of molecular tumour alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma. Gynecol. Oncol.. 2014;133:197\u2013204.","DOI":"10.1016\/j.ygyno.2014.02.012"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumour marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0095","doi-asserted-by":"crossref","unstructured":"Rodolakis A, Biliatis I, Morice P, Reed N, Mangler M, Kesic V, et al. European Society of Gynecological Oncology Task Force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int. J. Gynecol. Cancer. 2015;25:1258\u201365.","DOI":"10.1097\/IGC.0000000000000493"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0105","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0110","first-page":"691","article-title":"Preserving fertility in young patients with endometrial cancer: current perspectives","volume":"6","author":"Kalogera","year":"2014","journal-title":"Int. J. Women's Health"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/IGC.0000000000000895","article-title":"Impact of conservative managements in young women with grade 2 or 3 endometrial adenocarcinoma confined to the endometrium","volume":"27","author":"Gonthier","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","article-title":"Coexisting ovarian malignancy in young women with endometrial cancer","volume":"106","author":"Walsh","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0125","doi-asserted-by":"crossref","unstructured":"McConechy MK, Talhouk A, Leung S, Chiu D, Yang W, Senz J, et al. Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis. Clin. Cancer Res.. 2016;22:2865\u201373.","DOI":"10.1158\/1078-0432.CCR-15-2233"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0130","doi-asserted-by":"crossref","unstructured":"Church DN, Stelloo E, Nout RA, Valtcheva N, Depreeuw J, ter Haar N, et al. Prognostic significance of POLE proofreading mutations in endometrial cancer. J. Natl. Cancer Inst. 2015;107:402.","DOI":"10.1093\/jnci\/dju402"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cncr.29046","article-title":"Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for lynch syndrome testing","volume":"121","author":"Billingsley","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-43139-0_1","article-title":"Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences","volume":"943","author":"Felix","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0145","doi-asserted-by":"crossref","unstructured":"Guttery DS, Blighe K, Polymeros K, Symonds RP, Macip S, Moss EL. Racial differences in endometrial cancer molecular portraits in the cancer genome atlas. Oncotarget. 2018;9:17093\u2013103.","DOI":"10.18632\/oncotarget.24907"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0150","first-page":"357","article-title":"Endometrial cancer in Asian migrants to the United States and their descendants","volume":"14","author":"Liao","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0155","doi-asserted-by":"crossref","unstructured":"Kolonel LN, Henderson BE, Hankin JH, Nomura AM, Wilkens LR, Pike MC, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am. J. Epidemiol.. 2000;151:346\u201357.","DOI":"10.1093\/oxfordjournals.aje.a010213"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0160","doi-asserted-by":"crossref","unstructured":"Yamamoto-Honda R, Takahashi Y, Yoshida Y, Kwazu S, Iwamoto Y, Kajio H, et al. Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: results from the National Center Diabetes Database. J Diabetes Investig. 2016;7:908\u201314.","DOI":"10.1111\/jdi.12522"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/aje\/kwk010","article-title":"Racial\/ethnic differences in endometrial cancer risk: the multiethnic cohort study","volume":"165","author":"Setiawan","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0170","doi-asserted-by":"crossref","unstructured":"Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, et al. Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol. Oncol.. 2007;104:52\u20137.","DOI":"10.1016\/j.ygyno.2006.07.003"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0175","doi-asserted-by":"crossref","unstructured":"Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, et al. Synchronous endometrial and ovarian carcinomas: evidence of clonality. J. Natl. Cancer Inst. 2016;108:djv428.","DOI":"10.1093\/jnci\/djv428"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0180","doi-asserted-by":"crossref","unstructured":"Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, et al. Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas. J. Natl. Cancer Inst. 2016;108:(djv427).","DOI":"10.1093\/jnci\/djv427"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0185","doi-asserted-by":"crossref","unstructured":"Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, et al. Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet. Gynecol.. 2013;122:7\u201314.","DOI":"10.1097\/AOG.0b013e3182964ce3"},{"issue":"266","key":"10.1016\/j.ygyno.2019.03.098_bb0190","first-page":"e1","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.03.098_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008034","article-title":"Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review","volume":"96","author":"Wei","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ygyno.2019.03.098_bb0200","doi-asserted-by":"crossref","unstructured":"Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome. JAMA. 2011;305:2304\u201310.","DOI":"10.1001\/jama.2011.743"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819302719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819302719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:46:45Z","timestamp":1758772005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819302719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0090825819302719"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.098","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}